VOSEVI TABLET FILMOMHULD

Active substance
SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR
Therapeutical formulation
TABLETTEN EN CAPSULES

€ 545.00 € 15,260.00 excluding delivery costs.

This drug is fully reimbursed by your health insurance company.

Own risk

€ 545.00 € 15,260.00

This is the amount charged to your deductible per piece per package.

Strength
400/100/100MG
Supplier
GILEAD SCIENCES NETHERLANDS BV
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
EU number
EU/1/17/1223/001

See also